RA0308

antibody from Oursmab

Targeting: IFNA2 IFN-alphaA, IFNA

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0308

Provider

Oursmab

Product name

Sifalimumab (Biosimilar Reference Antibody) (IFNA1)

Antibody type

Monoclonal

Description

Sifalimumab is a fully human monoclonal antibody targeting interferon-alpha (IFN-¦Á), a key cytokine in systemic lupus erythematosus (SLE) pathogenesis. It neutralizes multiple IFN-¦Á subtypes, aiming to reduce the "interferon signature" and dampen autoimmune activity. It was investigated in clinical trials for moderate-to-severe SLE.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg-500,10 mg,25 mg,50 mg,752 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

store at -20¡ãC or -80¡ãC. Avoid repeated freeze.